NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
VERU Shareholders Click Here: https://www.zlk.com/pslra-1/veru-lawsuit-loss-submission-form?prid=36155&wire=1
EYE Shareholders Click Here: https://www.zlk.com/pslra-1/national-vision-class-action-submission-form?prid=36155&wire=1
ARBK Shareholders Click Here: https://www.zlk.com/pslra-1/argo-blockchain-lawsuit-submission-form?prid=36155&wire=1
* ADDITIONAL INFORMATION BELOW *
Veru Inc. (NASDAQ:VERU)
This lawsuit is on behalf of all investors who purchased or otherwise acquired Veru Inc. common stock between May 11, 2022 and November 9, 2022, inclusive.
Lead Plaintiff Deadline : February 6, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/veru-lawsuit-loss-submission-form?prid=36155&wire=1
According to the filed complaint, 1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company's interactions with the United States Food and Drug Administration; 2) defendants misled Veru's shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization ("EUA") and even the submission of a New Drug Application without any further studies; and 3) the Company's filings concealed the true risks faced by Veru in gaining approval for its EUA request.
National Vision Holdings, Inc. (NASDAQ:EYE)
This lawsuit is on behalf of all persons who purchased shares of National Vision common stock between May 13, 2021, and May 9, 2022, both dates inclusive.
Lead Plaintiff Deadline : March 28, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/national-vision-class-action-submission-form?prid=36155&wire=1
According to the filed complaint, (a) National Vision was experiencing extraordinary wage and labor pressures as a result of intense competition and disruptions in the labor market due to the COVID-19 pandemic; (b) National Vision had made a significant multi-million dollar investment in wage and compensation payments to its vision care professionals in order to prevent mass defections in the middle of 2021; (c) the enhanced payouts were expected to negatively impact the Company's fourth quarter 2021 costs and profit margins to an extent materially greater than what had been disclosed to investors; (d) as a result of (a)-(c) above, the Company's profitability metrics were expected to deteriorate below not only favorable 2020 results, but also pre-pandemic levels; e) the Company's recruitment and retention efforts had not been successful and there was a substantial undisclosed risk that National Vision would experience staff and optometrist shortages and capacity constraints.
Argo Blockchain plc (NASDAQ:ARBK)
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Argo American Depository Shares pursuant and/or traceable to the documents issued in connection with the Company's initial public offering conducted on or about September 23, 2021; and/or (b) Argo securities between September 23, 2021 and October 10, 2022, both dates inclusive.
Lead Plaintiff Deadline : March 27, 2023
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/argo-blockchain-lawsuit-submission-form?prid=36155&wire=1
According to the filed complaint, (i) Argo was highly susceptible to and/or suffered from significant capital constraints, electricity and other costs, and network difficulties; (ii) the foregoing issues hampered Argo's ability to mine Bitcoin or Bitcoin equivalents, execute its business strategy, meet its obligations, and operate its Helios facility; (iii) as a result, Argo's business was less sustainable than defendants had led investors to believe; (iv) accordingly, Argo's business and financial prospects were overstated; and (v) as a result, the documents issued in connection with the Company's initial public offering and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
SOURCE: Levi & Korsinsky, LLP